Metabolic Syndrome Among People Living With HIV on Dolutegravir and Efavirenz-Based Antiretroviral Therapy in Ethiopia: A Comparative Cross-Sectional Study
The prevalence of metabolic syndrome was significantly higher among PLWH on DTG-based regimens. This signifies that DTG-treated patients should be advised on lifestyle adjustments to prevent the development of metabolic syndrome.
Authors
- Mamaru Getinet (ORCID: https://orcid.org/0000-0003-3570-5695)
- Mohammed Jemal (ORCID: https://orcid.org/0009-0000-6700-9972)
- Adane Adugna (ORCID: https://orcid.org/0000-0003-1467-2724)
- Temesgen Baylie (ORCID: https://orcid.org/0009-0005-8371-3202)
- Nuredin Chura Waritu (ORCID: https://orcid.org/0009-0000-1468-4640)
- Baye Ashenef
- Deresse Sinamaw
Institutions
- Wolaita Sodo University (ET)
- Debre Markos University (ET)
Publication Details
- Journal
- Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1177/23259582241303305
- Citations
- 5
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.45
Funders
- University of Gondar